NOTCH4 and neoplasm: Providing a feedback mechanism, another study has found that the inhibition of Notch signaling or the suppression of Notch4/DLL3 leads to a decrease in endothelial markers and the function of tumor-derived endothelial cells following treatment with adriamycin or paclitaxel via VEGF receptor (Zhang et al., 2016).